| Donald V Jablonski, MD | |
|
1812 N Mills Ave, Orlando, FL 32803-1854 | |
| (407) 897-3499 | |
| (407) 894-8746 |
| Full Name | Donald V Jablonski |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 1812 N Mills Ave, Orlando, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265428957 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | ME14504 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Donald V Jablonski, MD 1812 N Mills Ave, Orlando, FL 32803-1854 Ph: (407) 897-3499 | Donald V Jablonski, MD 1812 N Mills Ave, Orlando, FL 32803-1854 Ph: (407) 897-3499 |
News Archive
As announced on November 17, 2010, certain members (the "Petitioning Creditors") of the Ad Hoc Group of Vitro Noteholders (the "Ad Hoc Noteholder Group"), comprised of holders, or investment advisors to holders, of the Senior Notes due 2012, 2013 and 2017 (collectively, the "Senior Notes") issued by Vitro S.A.B. de C.V. ("Vitro"), commenced involuntary bankruptcy cases (the "Cases") under chapter 11 of the U.S. Bankruptcy Code against fifteen of Vitro's U.S. subsidiary guarantors (the "U.S. Subsidiary Debtors").
Navidea Biopharmaceuticals, Inc., a specialty pharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its Phase 3 clinical study investigating 99m-Tc-Tilmanocept in oral and squamous cell cancers (SCC) were presented as a poster presentation at the 65th Annual Cancer Symposium of the Society of Surgical Oncology (SSO) meeting held in Orlando, Florida, March 21-24, 2012.
News outlets covering the health reform debate noted that Republicans are continuing their arguments against Democratic legislation and outlined what might happen in the coming week in the Senate.
While adults make up 95 percent of those who die annually from vaccine preventable diseases, a new study from the University of Colorado School of Medicine shows their vaccination rates remain stubbornly low, representing a growing public health concern.
› Verified 1 days ago
Robert Anthony Badalament, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-897-3499 Fax: 407-896-9454 | |
Nabil Hilwa, MD Urology Medicare: Medicare Enrolled Practice Location: 7301 Stonerock Cir, Orlando, FL 32819 Phone: 407-298-6950 Fax: 407-578-2354 | |
Dr. George Frederick Ellis, MD Urology Medicare: Medicare Enrolled Practice Location: 89 W Copeland Dr, Orlando, FL 32806 Phone: 321-842-6910 Fax: 321-843-5998 | |
Albert Michael Ong, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 41 W Kaley St, Orlando, FL 32806 Phone: 407-843-6645 Fax: 407-843-4519 | |
Jason Cheng-en Sea, MD, FRCSC Urology Medicare: Accepting Medicare Assignments Practice Location: 2101 Park Center Dr Ste 130, Orlando, FL 32835 Phone: 407-298-6950 Fax: 407-578-2354 | |
Joshua Adam Earl, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1812 N Mills Ave, Orlando, FL 32803 Phone: 407-897-3499 Fax: 407-896-9454 | |
Dr. Lucas Ross Wiegand, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 303 E Par St, Orlando, FL 32804 Phone: 877-876-3627 Fax: 321-843-4101 |